These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 49383)

  • 1. Morphological responses of benign human prostatic hypertrophic tissue to chemotherapeutic agents in an in vitro culture system.
    Varkarakis MJ; Gaeta JF; Mirand EA; Murphy GP
    J Med; 1975; 6(1):65-71. PubMed ID: 49383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy of prostatic cancer].
    Portnoĭ AS
    Vopr Onkol; 1985; 31(9):3-12. PubMed ID: 2931901
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone regulation of human prostate in organ culture.
    Nevalainen MT; Härkönen PL; Valve EM; Ping W; Nurmi M; Martikainen PM
    Cancer Res; 1993 Nov; 53(21):5199-207. PubMed ID: 7693334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on carcinogenesis of human prostate. III. Long-term explant culture of normal prostate and benign prostatic hyperplasia: transmission and scanning electron microscopy.
    Heatfield BM; Sanefuji H; Trump BF
    J Natl Cancer Inst; 1982 Oct; 69(4):757-66. PubMed ID: 6181280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy of advanced prostate cancer].
    Murphy GP
    Vopr Onkol; 1977; 23(12):26-38. PubMed ID: 146305
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy programs of the National Prostatic Cancer Project (NPCP).
    Schmidt JD; Scott WW; Gibbons R; Johnson DE; Prout GR; Loening S; Soloway M; deKernion JB; Pontes JE; Slack NH; Murphy GP
    Cancer; 1980 Apr; 45(7 Suppl):1937-46. PubMed ID: 6445225
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
    Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
    Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on carcinogenesis of human prostate. II. Long-term explant culture of normal prostate and benign prostatic hyperplasia: light microscopy.
    Sanefuji H; Heatfield BM; Trump BF; Young JD
    J Natl Cancer Inst; 1982 Oct; 69(4):751-6. PubMed ID: 6181279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues.
    Camiolo SM; Markus G; Englander LS; Siuta MR; Hobika GH; Kohga S
    Cancer Res; 1984 Jan; 44(1):311-8. PubMed ID: 6197164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in guinea pig prostatic stroma.
    Horsfall DJ; Mayne K; Ricciardelli C; Rao M; Skinner JM; Henderson DW; Marshall VR; Tilley WD
    Lab Invest; 1994 May; 70(5):753-63. PubMed ID: 8196369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural and biophysical studies on protein conformations of epithelium and stroma in benign prostatic hyperplasia before and after transurethral resection of the prostate.
    Hsu HS; Lin SY; Li MJ; Liang RC
    Ultrastruct Pathol; 2002; 26(3):137-41. PubMed ID: 12184371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines.
    Pflug BR; Onoda M; Lynch JH; Djakiew D
    Cancer Res; 1992 Oct; 52(19):5403-6. PubMed ID: 1382843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography].
    Suzuki K; Ichinose Y; Hashimoto K; Matsumoto K; Suzuki T; Imai K; Yamanaka H
    Hinyokika Kiyo; 1990 May; 36(5):557-60. PubMed ID: 1698012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Organ culture of human tissue as study model of hormonal and pharmacological regulation of benign prostatic hyperplasia and of prostatic cancer].
    Janssen T; Kiss R; Schulman C
    Acta Urol Belg; 1995 Mar; 63(1):7-14. PubMed ID: 7537011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia].
    Santa María Margalef A; Paciucci Barzanti R; Reventós Puigjaner J; Morote Robles J; Thomson Okatsu TM
    Arch Esp Urol; 2003 May; 56(4):369-78. PubMed ID: 12830609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative control of epithelial cell proliferation by prostatic stroma.
    Kooistra A; König JJ; Romijn JC; Schröder FH
    Anticancer Res; 1991; 11(4):1495-500. PubMed ID: 1720936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia: age-related tissue-remodeling.
    Untergasser G; Madersbacher S; Berger P
    Exp Gerontol; 2005 Mar; 40(3):121-8. PubMed ID: 15763388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathological aspects of the treatment of benign prostatic hypertrophy. Role of prostatic stroma and estrogens].
    Solè-Balcells F
    J Urol (Paris); 1993; 99(6):303-6. PubMed ID: 7516373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.